Human essentiality genes and targeted oncology therapies
Andrew Robert HarperiD, Ultan McDermottiD, Slavé PetrovskiiD
Abstract
Human essentiality genes are significantly enriched in targeted therapies successfully used in oncology. Embedding human essentiality metrics into discovery pipelines could optimise the delivery of highly effective targeted therapies among clinical development strategies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genome-wide investigation of gene-cancer associations for the prediction of novel therapeutic targets in oncology
Adrián Bazaga, Dan Leggate, Hendrik Weisser·Scientific ReportsPeer-reviewed·Jul 1, 2020
- Agent-Driven Validation of Oncology Therapeutic Targets
Kuan-lin Huang·bioRxiv·May 3, 2026
- Tissue-specific genes as an underutilized resource in drug discovery
Maria Ryaboshapkina, Mårten Hammar·Scientific ReportsPeer-reviewed·May 10, 2019
- Mechanism-aware inference of response to targeted cancer therapies
Nilabja Bhattacharjee, Sreeram Chandra Murthy Peela, … Debarka Sengupta·bioRxiv·Sep 4, 2025
- Expression-Driven Genetic Dependency Reveals Targets for Precision Medicine
Abdülkadir Elmas, Hillary M. Layden, … Kuan‐lin Huang·bioRxiv·Oct 17, 2024
- Cellular Fitness Phenotypes of Cancer Target Genes from Oncobiology to Cancer Therapeutics
B. George, A. M. Paul, … R. Kumar·bioRxiv·Jan 28, 2021